AARDVARK THERAPEUTICS
LIVE

Serial Number

98857292

Owner

AARDVARK THERAPEUTICS, INC.

Attorney

Elise Wu

Filing Date

Nov 16, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AARDVARK THERAPEUTICS Trademark

Serial Number: 98857292

AARDVARK THERAPEUTICS is a trademark filed by AARDVARK THERAPEUTICS, INC. on November 16, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

AARDVARK THERAPEUTICS, INC. (4 trademarks)

4370 La Jolla Village Drive, Suite 1050
San Diego, CA 92122

Entity Type: 03

Trademark Details

Filing Date

November 16, 2024

Registration Date

Not Registered

Published for Opposition

July 29, 2025

Goods & Services

Medical and scientific research and development in the fields of diagnosis and treatment of neuro-psychological disorders, autism, metabolic and inflammatory conditions, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; providing medical and scientific research information in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; medical and scientific research, namely, conducting clinical trials for others for pharmaceuticals, drug development, and therapeutic applications in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; clinical research in the field of neuro-psychological disorders, autism, metabolic and inflammatory diseases, and obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity.

Therapeutic pharmaceuticals for the treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; therapeutic pharmaceuticals for cancer treatment and management; abuse-deterrent pharmaceutical preparations for treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity.

Filing History

ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Aug 12, 2026 INCD
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 3, 2026 TROA
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Jul 23, 2026 INCD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 22, 2026 AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 23, 2026 AITU
TEAS REQUEST TO DIVIDE RECEIVED
Mar 23, 2026 ERTD
TEAS STATEMENT OF USE RECEIVED
Mar 23, 2026 EISU
SOU TEAS EXTENSION RECEIVED
Mar 23, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 23, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 29, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 29, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 23, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 24, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 23, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 23, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 14, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 14, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 14, 2025 CNRT
ASSIGNED TO EXAMINER
May 12, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2025 NWOS
NEW APPLICATION ENTERED
Nov 16, 2024 NWAP